- Home
- BWBBP vs SRPT Comparison
BWBBP vs SRPT Comparison
Compare BWBBP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWBBP
- SRPT
- Stock Information
- Founded
- BWBBP N/A
- SRPT 1980
- Country
- BWBBP United States
- SRPT United States
- Employees
- BWBBP 290
- SRPT N/A
- Industry
- BWBBP Major Banks
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- BWBBP Finance
- SRPT Health Care
- Exchange
- BWBBP Nasdaq
- SRPT Nasdaq
- Market Cap
- BWBBP N/A
- SRPT N/A
- IPO Year
- BWBBP N/A
- SRPT 1997
- Fundamental
- Price
- BWBBP $18.84
- SRPT $43.26
- Analyst Decision
- BWBBP
- SRPT Buy
- Analyst Count
- BWBBP 0
- SRPT 23
- Target Price
- BWBBP N/A
- SRPT $125.43
- AVG Volume (30 Days)
- BWBBP N/A
- SRPT 4.2M
- Earning Date
- BWBBP N/A
- SRPT 08-06-2025
- Dividend Yield
- BWBBP N/A
- SRPT N/A
- EPS Growth
- BWBBP N/A
- SRPT N/A
- EPS
- BWBBP N/A
- SRPT N/A
- Revenue
- BWBBP N/A
- SRPT $2,233,371,000.00
- Revenue This Year
- BWBBP N/A
- SRPT $37.38
- Revenue Next Year
- BWBBP N/A
- SRPT $13.05
- P/E Ratio
- BWBBP N/A
- SRPT N/A
- Revenue Growth
- BWBBP N/A
- SRPT 59.15
- 52 Week Low
- BWBBP N/A
- SRPT $34.10
- 52 Week High
- BWBBP N/A
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- BWBBP 51.07
- SRPT 45.81
- Support Level
- BWBBP $18.42
- SRPT $37.91
- Resistance Level
- BWBBP $19.09
- SRPT $39.56
- Average True Range (ATR)
- BWBBP 0.12
- SRPT 2.12
- MACD
- BWBBP -0.00
- SRPT 1.35
- Stochastic Oscillator
- BWBBP 61.74
- SRPT 69.12
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.